Shares of pharmaceutical companies fell across the world after US President Donald Trump said he planned to order a cut in US ...

President Donald Trump said he plans to order a cut in US prescription drug costs by mandating that Americans pay no more ...

Takeda Pharmaceuticals delivered strong FY2024 results and offers value with a 4.81% yield, despite pressure from Vyvanse ...

China’s exports surged as shipments to Southeast Asian countries soared, offsetting a sharp drop in outbound goods to the U.S ...

Shares of Asian pharmaceutical companies fell after US President Donald Trump said he planned to order a cut in US ...

Shares of Asian pharmaceutical companies fell after US President Donald Trump said he planned to order a cut in US ...

The U.S. president's social media post put pressure on drug-related stocks on worries their profits will take a hit if they ...

Indian pharmaceutical stocks fell sharply after U.S. President Donald Trump announced a push to lower domestic drug prices ...

The president is planning Monday to revive a plan from his first term, which would peg the prices the United States pays for ...

He plans to sign an executive order to cut prescription drug prices. Read more at straitstimes.com. Read more at straitstimes ...

The announcement has sent share prices of pharmaceuticals companies around the world tumbling. Japanese companies Chugai ...

Trump’s drug pricing order sparks global pharma sell-off as industry warns of stifled innovation and revenue loss in key US ...